Coya Therapeutics, Inc.
COYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $28,130 | $29,757 | $35,531 | $38,340 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $731 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3,895 | $3,670 | $2,843 | $5,238 |
| Total Curr. Assets | $32,025 | $33,428 | $38,373 | $44,308 |
| Property Plant & Equip (Net) | $18 | $25 | $32 | $39 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$0 | $0 | $0 |
| Total NC Assets | $18 | $25 | $32 | $39 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32,043 | $33,453 | $38,405 | $44,347 |
| Liabilities | – | – | – | – |
| Payables | $1,112 | $931 | $1,690 | $1,588 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $917 | $0 | $841 | $848 |
| Other Curr. Liab. | $1,639 | $3,570 | $1,810 | $1,388 |
| Total Curr. Liab. | $3,667 | $4,501 | $4,341 | $3,824 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $1,091 | $0 | $694 | $945 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $641 | $0 | $0 |
| Total NC Liab. | $1,091 | $641 | $694 | $945 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,758 | $5,142 | $5,035 | $4,770 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$56,255 | -$54,139 | -$48,044 | -$40,737 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $83,538 | $82,448 | $81,412 | $80,313 |
| Total Equity | $27,284 | $28,310 | $33,370 | $39,577 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $32,043 | $33,453 | $38,405 | $44,347 |
| Net Debt | -$28,130 | -$29,757 | -$35,531 | -$38,340 |